PLA/PLGA nanoparticles for sustained release of docetaxel

International Journal of Pharmaceutics

Volumn 325, Issue 1-2, 2006, Pages 172-179

  Musumeci, T ^a   Ventura, C A ^b   Giannone, I ^a   Ruozi, B ^c   Montenegro, L ^a   Pignatello, R ^a   Puglisi, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Biomembrane models; Docetaxel; DSC; In vitro release; Nanoparticles; PLA PLGA

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; DOCETAXEL; NANOPARTICLE; POLYGLACTIN; POLYLACTIC ACID;

ARTICLE; BIODEGRADATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STRUCTURE; IN VITRO STUDY; LIGHT SCATTERING; LIPID VESICLE; MOLECULAR WEIGHT; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STRUCTURE ANALYSIS; SUSTAINED DRUG RELEASE; TRANSITION TEMPERATURE; ZETA POTENTIAL;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALORIMETRY, DIFFERENTIAL SCANNING; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG COMPOUNDING; ELECTROSTATICS; INJECTIONS, INTRAVENOUS; LACTIC ACID; LIPID BILAYERS; LIPOSOMES; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR WEIGHT; NANOPARTICLES; NANOTECHNOLOGY; POLYGLYCOLIC ACID; POLYMERS; STATIC ELECTRICITY; SURFACE PROPERTIES; TAXOIDS; TIME FACTORS;

EID: 33750031510     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.06.023     Document Type: Article

References (28)

1. Aapro M., and Bruno R. Early clinical studies with docetaxel. Eur. J. Cancer 31A (1995) S7-S10
2. Aapro M. The scientific rationale for developing taxoids. Anticancer Drugs 7 (1996) 33-36
3. Alexopoulos A., Karamouzis M.V., Stavrinides H., Ardavanis A., Kandilis K., Stavrakakis J., Georganta C., and Rigatos G. Phase II study of pegylated liposomal doxorubicin (caelyx) and docetaxel as first-line treatment in metastatic breast cancer. Ann. Oncol. 15 (2004) 891-895
4. Baker S.D., Zhao M., He P., Carducci M.A., Verweij J., and Sparreboom A. Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometry. Anal. Biochem. 324 (2004) 276-284
5. Barratt G.M. Therapeutic applications of colloidal drug carriers. Pharm. Sci. Technol. Today 3 (2000) 163-171
6. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 234 (1959) 466-468
7. Brigger I., Dubernet C., and Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54 (2002) 631-651
8. Davda J., and Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int. J. Pharm. 233 (2002) 51-59
9. Dubernet C. Thermoanalysis of microspheres. Thermochim. Acta 248 (1995) 259-269
10. Estep T.N., Mountcastle D.B., Biltonen R.L., and Thompson T.E. Thermal behaviour of synthetic sphingomyelin-cholesterol dispersion. Biochemistry 18 (1978) 2112-2117
11. Gelderblom H., Verweij J., Nooter K., and Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 37 (2001) 1590-1598
12. Giannavola C., Bucolo C., Maltese A., Paolino D., Vandelli M.A., Puglisi G., Lee V.H., and Fresta M. Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability. Pharm. Res. 20 (2003) 584-590
13. Grosse P.Y., Bressolle F., and Pinguet F. In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-β-cyclodextrin. Eur. J. Cancer 34 (1998) 168-174
14. Herbst R.S., and Khuri R. Mode of action of docetaxel a basis for combination with novel anticancer agents. Cancer Treat. Rev. 29 (2003) 407-415
15. Holland, S.J., Tighe, B.J., 1992. Biodegradable polymers. In: Garderton, D., Jones, T. (Eds.), Advances in Pharmaceutical Science, vol. 6. New York, pp. 101-164.
16. Immordino M.L., Brusa P., Arpicco S., Stella B., Dosio F., and Cattel L. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J. Contr. Release 91 (2003) 417-429
17. Jain M.K. Properties of bilayer. In: Jain M.K. (Ed). Introduction to Biological Membranes (1988), John Wiley & Sons Inc., New York 86-121
18. Jain M.K. Order and dynamics in bilayers and solute in bilayers. In: Jain M.K. (Ed). Introduction to Biological Membranes (1988), John Wiley & Sons Inc., New York 122-146
19. Layre A.M., Gref R., Richard J., Requier D., Chacun H., Appel M., Domb A.J., and Couvreur P. Nanoencapsulation of a crystalline drug. Int. J. Pharm. 298 (2005) 323-327
20. Magenheim B., Levy M.Y., and Benita S. A new in vitro technique for evaluation of drug release profile from colloidal carriers-ultrafiltration technique at low pressure. Int. J. Pharm. 94 (1993) 115-123
21. Mu L., and Feng S. PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio. Pharm. Res. 20 (2003) 1864-1872
22. ®): PLGA nanoparticles containing vitamin E TPGS. J. Contr. Release 86 (2003) 33-48
23. Müller R.H. Charge determinations. In: Müller R.H. (Ed). Colloidal Carriers for Controlled Drug Delivery and Targeting Modification, Characterization and In Vivo (1991), CRC Press, Boca Raton, FL 57-97
24. Müller R.H., Jacobs C., and Kayser O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 47 (2001) 3-19
25. Musumeci, T., Vicari, L., Ventura, C., Gulisano, M., Pignatello, R., Puglisi, G., in press. Lyoprotected nanospheres formulations for paclitaxel controlled delivery. J. Nanosci. Nanotechnol.
26. Perracchia M.T., Vauthier C., Desmaele D., Gulik A., Dedieu J.C., Demoy M., D'Angelo J., and Couvreur P. Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer. Pharm. Res. 15 (1998) 550-556
27. Smith N.F., Acharya M.R., Desai N., Figg W.D., and Sparreboom A. Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel. Cancer Biol. Ther. 4 (2005)
28. Zhao L., and Feng S. Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model biomembrane. J. Colloid Int. Sci. 274 (2004) 55-68